Your browser (Internet Explorer 7 or lower) is out of date. It has known security flaws and may not display all features of this and other websites. Learn how to update your browser.

X

Navigate / search

Integrated Approaches to HIV-Related Heart, Lung, Blood, and Sleep (HLBS) Comorbidities (R01)

Key Dates: 

Posted Date: November 23, 2016

Open Date (Earliest Submission Date): March 25, 2017

Letter of Intent Due Date(s): 30 days prior to the application due date

Application Due Date(s): April 25, 2017 and December 15, 2017, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

AIDS Application Due Date(s): April 25, 2017 and December 15, 2017, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Scientific Merit Review: July 2017 and March 2018

Advisory Council Review: October 2017 and June 2018

Earliest Start Date: December 2017 and July 2018

Purpose: 

This Funding Opportunity Announcement (FOA) invites research project grant (R01) applications that propose "systems biology" approaches using clinical samples from HIV-infected patients to elucidate the biological perturbations associated with HIV-related heart, lung, blood, and sleep (HLBS) comorbidities. The ultimate goal is to better understand disease progression, which may help identify new therapeutic targets that pre-empt the onset of HLB diseases and sleep disorders in the HIV population.

Expiration Date: 
Sunday, December 17, 2017
Announcement Number: 
RFA-HL-18-004